Full Name
Kam Man Hui
Variants
HUI, KAM MAN
Hui, K.M.
HUI, KAM M.
Hui, K.
 
 
 
Email
gmshkm@nus.edu.sg
 
 

Refined By:
Date Issued:  [2000 TO 2023]
Department:  DUKE-NUS MEDICAL SCHOOL
Department:  INSTITUTE OF MOLECULAR & CELL BIOLOGY

Results 21-30 of 30 (Search time: 0.008 seconds).

Issue DateTitleAuthor(s)
212019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
222-Nov-2021PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)Thura, Min; Al-Aidaroos, Abdul Qader; Gupta, Abhishek ; Chee, Cheng Ean ; Lee, Soo Chin ; Hui, Kam Man ; Li, Jie; Guan, Yeoh Khay ; Yong, Wei Peng ; So, Jimmy; Chng, Wee Joo ; Ng, Chin Hin ; Zhou, Jianbiao ; Wang, Ling Zhi; Yuen, John Shyi Peng; Ho, Henry Sun Sien ; Yi, Sim Mei; Chiong, Edmund ; Choo, Su Pin ; Ngeow, Joanne; Ng, Matthew Chau Hsien ; Chua, Clarinda; Yeo, Eugene Shen Ann ; Tan, Iain Bee Huat ; Sng, Joel Xuan En; Tan, Nicholas Yan Zhi; Thiery, Jean Paul ; Goh, Boon Cher ; Zeng, Qi 
232019Relevance of a TCGA-derived Glioblastoma Subtype Gene-Classifier among Patient PopulationsTeo, W.-Y.; Sekar, K.; Seshachalam, P.; Shen, J.; Chow, W.-Y.; Lau, C.C.; Yang, H.K.; Park, J.; Kang, S.-G.; Li, X.; Nam, D.-H.; Hui, K.M. 
24Nov-2013Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growthOng, H.-T.; Federspiel, M.J.; Guo, C.M.; Ooi, L.L.; Russell, S.J.; Peng, K.-W.; Hui, K.M. 
252015The over-expression of survivin enhances the chemotherapeutic efficacy of YM155 in human hepatocellular carcinomaXia H.; Chen J.; Shi M.; Deivasigamani A.; Ooi L.L.P.J. ; Hui K.M. 
262018TIPE family of proteins and its implications in different chronic diseasesBordoloi D.; Banik K.; Shabnam B.; Padmavathi G.; Monisha J.; Arfuso F.; Dharmarajan A.; Mao X., Lim L.H.K. ; Wang L. ; Fan L. ; Hui K.M. ; Kumar A.P. ; Sethi G. ; Kunnumakkara A.B.
272014?-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen K.S. ; Ahn K.S.; Ong T.H.; Shanmugam M.K. ; Li F. ; Yap W.N.; Kumar A.P. ; Fong C.W.; Tergaonkar V. ; Hui K.M. ; Sethi G. 
2831-Oct-2021Tris(Dibenzylideneacetone)dipalladium(0) (tris dba) abrogates tumor progression in hepatocellular carcinoma and multiple myeloma preclinical models by regulating the stat3 signaling pathwayArora, Loukik; Mohan, Chakrabhavi Dhananjaya; Yang, Min Hee; Rangappa, Shobith; Deivasigamani, Amudha; Kumar, Alan Prem ; Kunnumakkara, Ajaikumar B.; Garg, Manoj; Chinnathambi, Arunachalam; Alharbi, Sulaiman Ali; Alahmadi, Tahani Awad; Rangappa, Kanchugarakoppal S.; Hui, Kam Man ; Sethi, Gautam ; Ahn, Kwang Seok
2915-Sep-2011Upregulation of Rac GTPase-activating protein 1 is significantly associated with the early recurrence of human hepatocellular carcinomaWang, S.M.; Ooi, L.L.P.J.; Hui, K.M. 
302014γ-tocotrienol inhibits angiogenesis-dependent growth of human hepatocellular carcinoma through abrogation of AKT/mTOR pathway in an orthotopic mouse modelSiveen, K.S.; Ahn, K.S.; Ong, T.H.; Shanmugam, M.K. ; Li, F.; Yap, W.N.; Kumar, A.P. ; Fong, C.W.; Tergaonkar, V.; Hui, K.M. ; Sethi, G.